We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Effective Breast-Conserving Surgery Results in Substantial Savings

By HospiMedica International staff writers
Posted on 08 Jan 2019
Print article
A new study suggests that if breast-conserving surgery (BCS) re-operation rates can be minimized, considerable funds can be saved.

Researchers at Imperial College London (Imperial; United Kingdom) and Imperial College Healthcare NHS Trust (London, United Kingdom) conducted a study to compare direct patient‐level costs between 153 patients undergoing successful, definitive BCS and 59 patients who necessitated reoperations. Financial data over the 12-month study period were retrieved using patient‐level information and costing systems (PLICS). In addition, a systematic review of health economic analysis was conducted using the quality of health economic studies (QHES) instrument.

The results revealed that the median cost of reoperations after BCS was USD 6,014, representing an additional USD 2,848 per patient compared with BCS without reoperation. The median QHES score was 47, with only two of nine studies scored in the upper QHES quartile (a score at least 75). Costs of initial lumpectomy and reoperation were in the range USD 1,234-11,786 and USD 655-9136, respectively. The study was published on December 19, 2018, in the British Journal of Surgery (BJS).

“High rates of reoperation following breast‐conserving surgery for positive margins are associated with costs to healthcare providers,” concluded lead author Yasmin Grant, PhD, of the Department of BioSurgery and Surgical Technology at Imperial College London, and colleagues. “If these cost estimates are applied nationally, they provide compelling encouragement to seek interventions to minimize re-operation after BCS, which would reduce associated costs.”

One of the root causes for the variability in repeat surgery rates for BCS is the lack of standardization of an acceptable margin width. No nationally or internationally accepted guidelines for an adequate margin width for invasive or noninvasive breast cancer have as yet been established, leading to considerable variability in BCS re-excision rates.

Related Links:
Imperial College London
Imperial College Healthcare NHS Trust

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Anatomic Glenoid System
Alliance Glenoid

Print article

Channels

Critical Care

view channel
Image: The largest scale analysis compared longer-term percutaneous devices for aortic valve replacement versus surgery (Photo courtesy of Adobe Stock)

Transcatheter Valve Replacement Outcomes Similar To Surgery, Finds Study

A new study has shown that a minimally invasive procedure for replacing the aortic valve in the heart—known as transcatheter aortic valve replacement (TAVR)—is on par with the more traditional surgical... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more